Tag Archives: pharmaceutical sector
Serbia’s biotech and health-tech push hinges on closing the commercialization gap
Serbia has deep scientific and engineering talent in medicine, life sciences and software, but its biotech sector remains small. The next test is whether the country…
Montenegro’s next growth bet: building a premium Adriatic health economy around prevention and digital care
Montenegro’s biotech and digital health prospects are unlikely to hinge on large-scale drug manufacturing. Instead, the country is positioning for a high-margin ecosystem that links preventive…
Montenegro’s healthcare and pharma market shifts from tourism support to long-term private demand
Montenegro’s pharmaceutical and private healthcare sector is moving into a structural growth phase as aging demographics, higher private spending, medical tourism potential and foreign residency demand…
Serbia’s healthcare and pharma growth meets limits from pricing rules, capital access and demand concentration
A Q4 2025 bulletin from Serbia’s Chamber of Commerce points to a sector generating steady value—€3.3 billion in gross value added in the pharmaceutical and healthcare…